Pharmacotherapies Targeting GABA-Glutamate Neurotransmission for Treatment-Resistant Depression
CM Vecera, A C. Courtes, G Jones, JC Soares… - Pharmaceuticals, 2023 - mdpi.com
Treatment-resistant depression (TRD) is a term used to describe a particular type of major
depressive disorder (MDD). There is no consensus about what defines TRD, with various …
depressive disorder (MDD). There is no consensus about what defines TRD, with various …
[HTML][HTML] A critical view on new and future antidepressants
A Serretti - Clinical Psychopharmacology and Neuroscience, 2024 - ncbi.nlm.nih.gov
For the first time after many decades, many new antidepressants have been approved and
many more are under various stages of development and will soon be available in the …
many more are under various stages of development and will soon be available in the …
A synopsis of multitarget therapeutic effects of anesthetics on depression
G Wu, H Xu - European Journal of Pharmacology, 2023 - Elsevier
Depression is a profound mental disorder that dampens the mood and undermines volition,
which exhibited an increased incidence over the years. Although drug-based interventions …
which exhibited an increased incidence over the years. Although drug-based interventions …
The pharmacological management of treatment-resistant depression: what does the future hold?
A Serretti - Expert Opinion on Pharmacotherapy, 2023 - Taylor & Francis
A Serretti is or has been a consultant to or has received honoraria or grants unrelated to the
present work from: Abbott, Abbvie, Angelini, Astra Zeneca, Clinical Data, Boheringer, Bristol …
present work from: Abbott, Abbvie, Angelini, Astra Zeneca, Clinical Data, Boheringer, Bristol …